UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Sep. 30, 2019	Dec. 31, 2018
Current assets:
Cash and cash equivalents	$ 296.3	$ 322.4
Short-term investments	6.1
Accounts receivable, net	358.8	357.2
Inventories	586.7	509.6
Other current assets	186.1	115.1
Total current assets	1,434.0	1,304.3
Property, plant and equipment, net	278.1	270.6
Goodwill	282.3	275.7
Operating lease assets	68.9
Intangibles, net and other long-term assets	288.8	278.0
Total assets	2,352.1	2,128.6
Current liabilities:
Current portion of long-term debt	0.3	18.5
Accounts payable	116.6	104.5
Customer advances	126.1	124.4
Other current liabilities	400.0	351.9
Total current liabilities	643.0	599.3
Long-term debt	518.5	322.6
Operating lease liabilities	50.7
Other long-term liabilities	264.3	279.0
Commitments and contingencies (Note 13)
Redeemable noncontrolling interest	20.9	22.6
Shareholders' equity:
Preferred stock, $0.01 par value 5,000,000 shares authorized, none issued or outstanding
Common stock, $0.01 par value 260,000,000 shares authorized, 173,292,361 and 172,634,220 shares issued and 153,945,784 and 156,609,340 shares outstanding at September 30, 2019 and December 31, 2018, respectively	1.7	1.7
Treasury stock, at cost, 19,346,577 and 16,024,880 shares at September 30, 2019 and December 31, 2018, respectively	(543.8)	(401.5)
Accumulated other comprehensive income	(18.8)	17.0
Other shareholders' equity	1,406.1	1,279.4
Total shareholders' equity attributable to Bruker Corporation	845.2	896.6
Noncontrolling interest in consolidated subsidiaries	9.5	8.5
Total shareholders' equity	854.7	905.1
Total liabilities and shareholders' equity	$ 2,352.1	$ 2,128.6